Details
Stereochemistry | MIXED |
Molecular Formula | C38H75O10P |
Molecular Weight | 722.9699 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC
InChI
InChIKey=BIABMEZBCHDPBV-BEBVUIBBSA-N
InChI=1S/C38H75O10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-37(41)45-33-36(34-47-49(43,44)46-32-35(40)31-39)48-38(42)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h35-36,39-40H,3-34H2,1-2H3,(H,43,44)/t35?,36-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11848282Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/11325729 | https://www.ncbi.nlm.nih.gov/pubmed/12460466
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11848282
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/11325729 | https://www.ncbi.nlm.nih.gov/pubmed/12460466
1,2-Dipalmitoyl-sn-glycero-3-phosphorylglycerol sodium salt (DPPG) is phosphorylglycerol acylated with palmitic acid, that can be used for the preparation of liposomes with negatively charged hydrophilic head groups.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | Unknown Approved UseUnknown |
|||
Inactive ingredient | Unknown Approved UseUnknown |
|||
Diagnostic | LUMASON Approved UseLumason is an ultrasound contrast agent indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. Launch Date2014 |
|||
Diagnostic | LUMASON Approved UseLumason is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions. Launch Date2014 |
|||
Diagnostic | LUMASON Approved UseLumason is indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux. Launch Date2014 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11325729
Samples containing 2.6 mmol of phospholipids (DMPCd54 plus either DMPA or DMPG at a 3:1 molar ratio) dissolved in chloroform/methanol (1:1 v/v) were mixed alone or with a-MSH, also in the same solvent, to give a final phospholipid to peptide molar ratio of 10:1. The mixtures were dried under vacuum for 3 h to remove all traces of the organic solvents. Then, multilamellar vesicles (MLV) were formed in 1.4 ml buffer heated at a temperature ;10°C above the temperature of the gel-to-liquid-crystalline phase transition (Tm) of the mixture and frozen at 280°C, this process being repeated five times. Differential scanning calorimetry was performed in a high-resolution Microcal MC-2 calorimeter (Microcal Inc., Northampton, MA). Differences in the heat capacity between the sample and the reference cell were obtained by raising the temperature at a constant rate of 45°C/h over a temperature range of 5–60°C. The excess heat capacity functions were obtained after baseline subtraction and correction for the instrument time response. Unless otherwise stated, the third scan was used for transition temperature and enthalpy calculation
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11846227
Created by
admin on Fri Dec 15 19:02:23 GMT 2023 , Edited by admin on Fri Dec 15 19:02:23 GMT 2023
|
PRIMARY | |||
|
85783
Created by
admin on Fri Dec 15 19:02:23 GMT 2023 , Edited by admin on Fri Dec 15 19:02:23 GMT 2023
|
PRIMARY | |||
|
5045XZ24IY
Created by
admin on Fri Dec 15 19:02:23 GMT 2023 , Edited by admin on Fri Dec 15 19:02:23 GMT 2023
|
PRIMARY | |||
|
DTXSID30225325
Created by
admin on Fri Dec 15 19:02:23 GMT 2023 , Edited by admin on Fri Dec 15 19:02:23 GMT 2023
|
PRIMARY | |||
|
1424658
Created by
admin on Fri Dec 15 19:02:23 GMT 2023 , Edited by admin on Fri Dec 15 19:02:23 GMT 2023
|
PRIMARY | RxNorm | ||
|
74313-95-4
Created by
admin on Fri Dec 15 19:02:23 GMT 2023 , Edited by admin on Fri Dec 15 19:02:23 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD